Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
98.38 EUR | -0.88% |
|
+0.56% | +4.45% |
Jun. 27 | Schott Pharma recovers - confirmation of annual targets is well received | DP |
Jun. 18 | GERRESHEIMER AG : Jefferies keeps its Buy rating | ZD |
Evolution of the average Target Price on Gerresheimer AG
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Gerresheimer AG
JEFFERIES | James Vane-Tempest |
DEUTSCHE BANK RESEARCH | Falko Friedrichs |
HAUCK AUFHÄUSER INVESTMENT BANKING | Alexander Galitsa |
DZ BANK | Sven Kürten |
BERENBERG | Victoria Lambert |
UBS | Olivier Calvet |
JPMORGAN | David Adlington |
BARCLAYS | Gaurav Jain |
CREDIT SUISSE | Christoph Gretler |
GOLDMAN SACHS | Veronika Dubajova |
DEUTSCHE BANK | Falko Friedrichs |
INDEPENDENT RESEARCH | Tobias Gottschalt |
KEPLER CHEUVREUX | Oliver Reinberg |
HAUCK & AUFHÄUSER | Aliaksandr Halitsa |
HSBC | Richard Latz |
EPS Revisions
- Stock Market
- Equities
- GXI Stock
- Consensus Gerresheimer AG